|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
218,850,000 |
Market
Cap: |
39.94(B) |
Last
Volume: |
90,505,923 |
Avg
Vol: |
10,608,554 |
52
Week Range: |
$182.5 - $182.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Thiel Carsten |
EVP, Chief Commercial Officer |
|
2017-02-06 |
4 |
S |
$125.69 |
$20,739 |
D/D |
(165) |
30,268 |
|
- |
|
Mackay Martin |
EVP & Global Head of R&D |
|
2017-02-06 |
4 |
S |
$125.69 |
$342,904 |
D/D |
(2,728) |
39,960 |
|
- |
|
Wagner Heidi L |
SVP, Global Government Affairs |
|
2017-02-06 |
4 |
S |
$125.69 |
$214,935 |
D/D |
(1,710) |
30,226 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-10 |
4 |
AS |
$144.99 |
$14,499 |
D/D |
(100) |
403,619 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-10 |
4 |
OE |
$22.90 |
$2,290 |
D/D |
100 |
403,719 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-09 |
4 |
AS |
$144.90 |
$48,397 |
I/I |
(334) |
403,285 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-09 |
4 |
AS |
$144.93 |
$703,345 |
D/D |
(4,853) |
403,619 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-09 |
4 |
OE |
$22.90 |
$111,134 |
D/D |
4,853 |
408,472 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-05 |
4 |
AS |
$134.90 |
$91,783 |
I/I |
(668) |
403,619 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-05 |
4 |
AS |
$135.07 |
$4,704,730 |
D/D |
(34,210) |
404,287 |
|
- |
|
Bell Leonard |
Director |
|
2017-01-05 |
4 |
OE |
$22.90 |
$783,409 |
D/D |
34,210 |
438,497 |
|
- |
|
Parven Alvin S |
Director |
|
2017-01-05 |
4 |
AS |
$133.65 |
$341,202 |
I/I |
(2,493) |
3,880 |
|
- |
|
Parven Alvin S |
Director |
|
2017-01-05 |
4 |
AS |
$133.95 |
$2,793,752 |
D/D |
(20,166) |
6,373 |
|
- |
|
Parven Alvin S |
Director |
|
2017-01-05 |
4 |
OE |
$26.64 |
$1,094,304 |
D/D |
20,166 |
26,539 |
|
- |
|
Moriarty John B |
EVP & General Counsel |
|
2016-12-12 |
4 |
S |
$118.61 |
$123,829 |
D/D |
(1,044) |
50,181 |
|
- |
|
Anderson David J |
EVP, Chief Financial Officer |
|
2016-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,689 |
8,689 |
|
- |
|
Thiel Carsten |
EVP, Chief Commercial Officer |
|
2016-12-09 |
4 |
AS |
$130.00 |
$300,040 |
D/D |
(2,308) |
30,433 |
|
- |
|
Wagner Heidi L |
SVP, Global Government Affairs |
|
2016-11-14 |
4 |
S |
$115.10 |
$6,791 |
D/D |
(59) |
31,936 |
|
- |
|
Bell Leonard |
Director |
|
2016-11-04 |
4 |
AS |
$136.00 |
$5,143,377 |
D/D |
(36,649) |
404,287 |
|
- |
|
Bell Leonard |
Director |
|
2016-11-04 |
4 |
OE |
$22.90 |
$839,262 |
D/D |
36,649 |
440,936 |
|
- |
|
Bell Leonard |
Director |
|
2016-11-04 |
4 |
AS |
$139.90 |
$95,123 |
I/I |
(668) |
404,287 |
|
- |
|
Bell Leonard |
Director |
|
2016-10-31 |
4 |
AS |
$135.37 |
$45,214 |
I/I |
(334) |
404,955 |
|
- |
|
Bell Leonard |
Director |
|
2016-10-31 |
4 |
AS |
$135.28 |
$175,864 |
D/D |
(1,300) |
405,289 |
|
- |
|
Bell Leonard |
Director |
|
2016-10-31 |
4 |
OE |
$22.90 |
$29,770 |
D/D |
1,300 |
406,589 |
|
- |
|
Thiel Carsten |
EVP, Chief Commercial Officer |
|
2016-10-14 |
4 |
AS |
$120.28 |
$551,364 |
D/D |
(4,584) |
32,741 |
|
- |
|
1501 Records found
|
|
Page 12 of 61 |
|
|